• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. biogen

biogen

Page 4 of 4

483106863
Health

Drug Companies Really Don’t Care About the Price Hike Backlash

By Industry Analyst
July 14, 2016
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?

Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?

By Damian Garde and STAT News
July 7, 2016
How Medical Researchers Are Breaking the Blood-Brain Barrier
Health

How Medical Researchers Are Breaking the Blood-Brain Barrier

By Investment Desk
June 28, 2016
Samsung Holds Shareholders Meeting
Tech

Samsung Has a Best-Selling American Drug in Its Crosshairs

By Trading Desk
May 24, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By Blockchain Reporter
May 6, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By Editorial Team
May 3, 2016
Biogen to Fire Workers, Restructure R&D After Difficult Year
Health

Why Biogen Is Spinning Off its Hemophilia Drug Business

By Editorial Team
May 3, 2016
547016547
Health

Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop

By Research Team
April 27, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Rise With Oil After Best Weekly Gain Since November
Finance

Here’s Why Biogen’s Shares Are Climbing Today

By Trading Desk
April 21, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By Blockchain Reporter
April 7, 2016
Light snow falls on the Dow Chemical Co. Michigan Operations
Leadership

Bathroom Battle Draws in Big Business

By Crypto Correspondent
March 25, 2016
Fight against Daesh in Turkey's Syrian borderline
Features

ISIS and drug sales — 5 things to know today

By Tom Huddleston Jr. and Geoffrey Smith
July 24, 2015
Apple Worldwide Developers Conference Opens In San Francisco
Features

Apple, Greek banks, and earnings — 5 things to know this week

By Market Analyst
July 19, 2015

Most Popular

  • AI
    Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
    By Crypto Correspondent
  • Economy
    One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
    By Digital Assets Editor
  • Economy
    Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
    By Senior Editor
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.